company background image
OCPH

October PharmaE CASE:OCPH Stock Report

Last Price

ج.م79.98

Market Cap

ج.م479.9m

7D

0%

1Y

39.1%

Updated

07 Dec, 2022

Data

Company Financials
OCPH fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health5/6
Dividends1/6

OCPH Stock Overview

October Pharma S.A.E manufactures and sells pharmaceutical products.

October Pharma S.A.E Competitors

Price History & Performance

Summary of all time highs, changes and price drops for October PharmaE
Historical stock prices
Current Share Priceج.م79.98
52 Week Highج.م87.50
52 Week Lowج.م57.51
Beta-0.012
1 Month Change0%
3 Month Change0%
1 Year Change39.07%
3 Year Change142.35%
5 Year Change127.17%
Change since IPO1,583.68%

Recent News & Updates

Recent updates

Shareholder Returns

OCPHEG PharmaceuticalsEG Market
7D0%9.0%7.0%
1Y39.1%19.7%19.3%

Return vs Industry: OCPH exceeded the EG Pharmaceuticals industry which returned 19.7% over the past year.

Return vs Market: OCPH exceeded the EG Market which returned 19.3% over the past year.

Price Volatility

Is OCPH's price volatile compared to industry and market?
OCPH volatility
OCPH Average Weekly Movement0%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement5.7%
10% most volatile stocks in EG Market9.0%
10% least volatile stocks in EG Market3.6%

Stable Share Price: OCPH is less volatile than 75% of EG stocks over the past 3 months, typically moving +/- 0% a week.

Volatility Over Time: OCPH's weekly volatility (0%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987n/an/ahttps://www.octoberpharma.com

October Pharma S.A.E manufactures and sells pharmaceutical products. The company offers cardiovascular, CNS, cold and chest, dermatology, diabetology, gastroenterology, hepatology, NSAID’s, and urology medicines, as well as antibiotics and multivitamins. It provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials.

October Pharma S.A.E Fundamentals Summary

How do October PharmaE's earnings and revenue compare to its market cap?
OCPH fundamental statistics
Market Capج.م479.85m
Earnings (TTM)ج.م119.79m
Revenue (TTM)ج.م655.04m

4.0x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
OCPH income statement (TTM)
Revenueج.م655.04m
Cost of Revenueج.م331.75m
Gross Profitج.م323.29m
Other Expensesج.م203.50m
Earningsج.م119.79m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)19.97
Gross Margin49.35%
Net Profit Margin18.29%
Debt/Equity Ratio21.5%

How did OCPH perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

15%

Payout Ratio